Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$7.2M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 38 most recent Form 4 transactions.
| — |
| — |
| Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 200 | $89.04 | $17.8K | -0.2% | Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 2,016 | $88.03 | $177.5K | -2.0% | Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 4,384 | $87.11 | $381.9K | -4.2% | Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 900 | $86.25 | $77.6K | -0.9% | Open the original filing on SEC.gov |
| Sep 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 7,500 | $14.50 | $108.8K | +7.6% | Open the original filing on SEC.gov |
| Aug 3 | SYRE | Spyre Therapeutics, Inc. | MEXER◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Aug 3 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 100 | $97.10 | $9.7K | -0.1% | Open the original filing on SEC.gov |
| Aug 3 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 2,300 | $96.30 | $221.5K | -2.3% | Open the original filing on SEC.gov |
| Aug 3 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 5,100 | $95.21 | $485.6K | -4.8% | Open the original filing on SEC.gov |
| Aug 3 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 7,500 | $14.50 | $108.8K | +7.6% | Open the original filing on SEC.gov |
| Jul 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Jul 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 1,725 | $88.37 | $152.4K | -1.7% | Open the original filing on SEC.gov |
| Jul 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 5,775 | $87.55 | $505.6K | -5.5% | Open the original filing on SEC.gov |
| Jul 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 7,500 | $14.50 | $108.8K | +7.6% | Open the original filing on SEC.gov |
| Jun 25 | SYRE | Spyre Therapeutics, Inc. | MEXER◆ | 15,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 25 | SYRE | Spyre Therapeutics, Inc. | SSELL | 10,000 | $87.14 | $871.4K | -9.3% | Open the original filing on SEC.gov |
| Jun 25 | SYRE | Spyre Therapeutics, Inc. | SSELL | 5,000 | $87.12 | $435.6K | -4.4% | Open the original filing on SEC.gov |
| Jun 25 | SYRE | Spyre Therapeutics, Inc. | MEXER | 15,000 | $14.50 | $217.5K | +15.3% | Open the original filing on SEC.gov |
| Jun 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 3,100 | $72.06 | $223.4K | -3.1% | Open the original filing on SEC.gov |
| Jun 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 2,599 | $70.77 | $183.9K | -2.5% | Open the original filing on SEC.gov |
| Jun 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 1,801 | $69.75 | $125.6K | -1.7% | Open the original filing on SEC.gov |
| Jun 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 7,500 | $14.50 | $108.8K | +7.6% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷◆ | 12,500 | — | — | — | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 12,500 | $71.37 | $892.1K | -11.3% | Open the original filing on SEC.gov |
| May 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 12,500 | $14.50 | $181.3K | +12.8% | Open the original filing on SEC.gov |
| Apr 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷◆ | 7,500 | — | — | — | Open the original filing on SEC.gov |
| Apr 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 1,300 | $49.98 | $65K | -1.3% | Open the original filing on SEC.gov |
| Apr 1 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 6,200 | $49.21 | $305.1K | -5.9% | Open the original filing on SEC.gov |
| Apr 1 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 7,500 | $14.50 | $108.8K | +7.6% | Open the original filing on SEC.gov |
| Mar 3 | SYRE | Spyre Therapeutics, Inc. | MEXER◷◆ | 2,500 | — | — | — | Open the original filing on SEC.gov |
| Mar 3 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 200 | $41.66 | $8.3K | -0.2% | Open the original filing on SEC.gov |
| Mar 3 | SYRE | Spyre Therapeutics, Inc. | SSELL◷ | 2,300 | $40.56 | $93.3K | -2.3% | Open the original filing on SEC.gov |
| Mar 3 | SYRE | Spyre Therapeutics, Inc. | MEXER◷ | 2,500 | $14.50 | $36.3K | +2.5% | Open the original filing on SEC.gov |
| Jan 9 | SYRE | Spyre Therapeutics, Inc. | AGRANT◆ | 140,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 2, 2025 | SYRE | Spyre Therapeutics, Inc. | SSELL | 18,428 | $16.26 | $299.6K | -15.8% | Open the original filing on SEC.gov |